Call Options

5 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 01, 2024

SELL
$309.38 - $337.38 $464,070 - $506,070
-1,500 Reduced 42.86%
2,000 $644 Million
Q2 2024

Aug 05, 2024

BUY
$262.75 - $319.31 $131,375 - $159,655
500 Added 16.67%
3,500 $1.09 Billion
Q1 2024

Apr 29, 2024

SELL
$268.87 - $324.56 $430,192 - $519,296
-1,600 Reduced 34.78%
3,000 $853 Million
Q4 2023

Jan 24, 2024

BUY
$255.7 - $288.46 $306,840 - $346,152
1,200 Added 35.29%
4,600 $1.32 Billion
Q3 2023

Nov 01, 2023

BUY
$218.65 - $271.46 $743,410 - $922,963
3,400 New
3,400 $914 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Xy Capital LTD Portfolio

Follow Xy Capital LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Xy Capital LTD, based on Form 13F filings with the SEC.

News

Stay updated on Xy Capital LTD with notifications on news.